What does CUSIP 03152W109 represent in this 13F holders report?

CUSIP 03152W109 is the security identifier for FOLD - AMICUS THERAPEUTICS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held FOLD - AMICUS THERAPEUTICS, INC. - Common Stock in Q2 2016?

124 institutional investors reported FOLD - AMICUS THERAPEUTICS, INC. - Common Stock for Q2 2016. Use the holders table for investor-level position and value details.

AMICUS THERAPEUTICS, INC. - Common Stock (FOLD)

CUSIP: 03152W109

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class: Equity / Common Stock
Shares outstanding: 312,579,912
Total 13F shares: 136,917,771
Share change: -2,082,430
Total reported value: $747,537,873
Put/Call ratio: 79%
Price per share: $5.46
Number of holders: 124
Value change: -$24,940,455
Number of buys: 78
Number of sells: 49

Quarterly Holders Quick Answers

What is CUSIP 03152W109?
CUSIP 03152W109 identifies FOLD - AMICUS THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2016
Previous quarter: Q1 2016

Recent filing periods for CUSIP 03152W109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	6%	18,723,103	$158,211,000	—	31 Mar 2016	13F
PERCEPTIVE ADVISORS LLC	13F	Company	4.9%	15,239,444	$128,773,000	—	31 Mar 2016	13F
Redmile Group, LLC	13F	Company	3.4%	10,718,420	$90,571,000	—	31 Mar 2016	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	3%	9,226,145	$77,961,000	—	31 Mar 2016	13F
VANGUARD GROUP INC	13F	Company	2.1%	6,509,450	$55,005,000	—	31 Mar 2016	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.9%	5,901,048	$49,864,000	—	31 Mar 2016	13F
JANUS HENDERSON INVESTORS US LLC	13F	Company	1.8%	5,616,508	$47,461,000	—	31 Mar 2016	13F
BlackRock Fund Advisors	13F	Company	1.7%	5,444,399	$46,005,000	—	31 Mar 2016	13F
JENNISON ASSOCIATES LLC	13F	Company	1.6%	5,141,046	$43,442,000	—	31 Mar 2016	13F
STATE STREET CORP	13F	Company	1.2%	3,819,430	$32,271,000	—	31 Mar 2016	13F
Palo Alto Investors LP	13F	Company	1.1%	3,551,173	$30,007,000	—	31 Mar 2016	13F
RS INVESTMENT MANAGEMENT CO LLC	13F	Company	1.1%	3,527,703	$29,809,000	—	31 Mar 2016	13F
Avoro Capital Advisors LLC	13F	Company	1.1%	3,424,104	$28,934,000	—	31 Mar 2016	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.94%	2,927,472	$24,737,000	—	31 Mar 2016	13F
FRAZIER MANAGEMENT LLC	13F	Company	0.93%	2,918,291	$24,660,000	—	31 Mar 2016	13F
D. E. Shaw & Co., Inc.	13F	Company	0.93%	2,903,472	$24,535,000	—	31 Mar 2016	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.8%	2,500,000	$21,125,000	—	31 Mar 2016	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	0.66%	2,053,225	$17,350,000	—	31 Mar 2016	13F
FRANKLIN RESOURCES INC	13F	Company	0.63%	1,969,500	$16,642,000	—	31 Mar 2016	13F
EMERALD ADVISERS, LLC	13F	Company	0.61%	1,897,821	$16,037,000	—	31 Mar 2016	13F
Morgenthaler Management Partners IX, LLC	13F	Company	0.57%	1,783,948	$15,074,000	—	31 Mar 2016	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.57%	1,778,151	$15,025,000	—	31 Mar 2016	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.43%	1,345,146	$11,367,000	—	31 Mar 2016	13F
NORTHERN TRUST CORP	13F	Company	0.42%	1,317,542	$11,134,000	—	31 Mar 2016	13F
JPMORGAN CHASE & CO	13F	Company	0.36%	1,138,342	$9,619,000	—	31 Mar 2016	13F
Invesco Ltd.	13F	Company	0.35%	1,099,329	$9,289,000	—	31 Mar 2016	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.34%	1,067,034	$9,017,000	—	31 Mar 2016	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.33%	1,038,773	$8,778,000	—	31 Mar 2016	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.27%	841,457	$7,110,000	—	31 Mar 2016	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.23%	714,977	$6,042,000	—	31 Mar 2016	13F
NORGES BANK	13F	Company	0.22%	680,030	$5,746,000	—	31 Mar 2016	13F
S.c.a. Candriam	13F	Individual	0.2%	619,900	$5,210,000	—	31 Mar 2016	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.2%	614,300	$5,191,000	—	31 Mar 2016	13F
Rock Springs Capital Management LP	13F	Company	0.2%	613,500	$5,184,000	—	31 Mar 2016	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.19%	595,060	$5,028,000	—	31 Mar 2016	13F
Asset Management One Co., Ltd.	13F	Company	0.19%	589,121	$4,707,000	—	31 Mar 2016	13F
Bank of New York Mellon Corp	13F	Company	0.17%	542,020	$4,580,000	—	31 Mar 2016	13F
HIGHLAND CAPITAL MANAGEMENT LP	13F	Company	0.17%	521,900	$4,410,000	—	31 Mar 2016	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.19%	607,500	$3,742,000	—	31 Mar 2016	13F
GW&K Investment Management, LLC	13F	Company	0.13%	417,435	$3,527,000	—	31 Mar 2016	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.13%	411,111	$3,474,000	—	31 Mar 2016	13F
BlackRock Investment Management, LLC	13F	Company	0.13%	396,235	$3,348,000	—	31 Mar 2016	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.11%	353,065	$2,983,000	—	31 Mar 2016	13F
Asymmetry Capital Management, L.P.	13F	Company	0.11%	333,513	$2,818,000	—	31 Mar 2016	13F
DEUTSCHE BANK AG\	13F	Company	0.1%	327,427	$2,766,000	—	31 Mar 2016	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.1%	300,000	$2,535,000	—	31 Mar 2016	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.1%	299,607	$2,532,000	—	31 Mar 2016	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.09%	279,400	$2,361,000	—	31 Mar 2016	13F
Tekla Capital Management LLC	13F	Company	0.08%	258,000	$2,180,000	—	31 Mar 2016	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.08%	245,513	$2,075,000	—	31 Mar 2016	13F

Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q2 2016

As of 30 Jun 2016, AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) was held by 124 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 136,917,771 shares. The largest 10 holders included FMR LLC, PERCEPTIVE ADVISORS LLC, Redmile Group, LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Fund Advisors, JANUS CAPITAL MANAGEMENT LLC, JENNISON ASSOCIATES LLC, SECTORAL ASSET MANAGEMENT INC, and STATE STREET CORP. This page lists 124 institutional shareholders reporting positions in this security for the Q2 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2016 vs Q1 2016 Across Filers

Q1 2016 holders

126

Q2 2016 holders

124

Holder diff

-2

Investor	Q1 2016 Shares	Q2 2016 Shares	Share Diff	Share Chg %	Q1 2016 Value $	Q2 2016 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.